349 related articles for article (PubMed ID: 37775641)
21. Epithelial to mesenchymal transition during mammalian neural crest cell delamination.
Zhao R; Trainor PA
Semin Cell Dev Biol; 2023 Mar; 138():54-67. PubMed ID: 35277330
[TBL] [Abstract][Full Text] [Related]
22. Tumor microenvironmental signaling elicits epithelial-mesenchymal plasticity through cooperation with transforming genetic events.
Junk DJ; Cipriano R; Bryson BL; Gilmore HL; Jackson MW
Neoplasia; 2013 Sep; 15(9):1100-9. PubMed ID: 24027434
[TBL] [Abstract][Full Text] [Related]
23. Epithelial-mesenchymal transition: When tumor cells meet myeloid-derived suppressor cells.
Cai J; Cui Y; Yang J; Wang S
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188564. PubMed ID: 33974950
[TBL] [Abstract][Full Text] [Related]
24. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
25. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
Garg M
Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
[TBL] [Abstract][Full Text] [Related]
26. EMT imparts cancer stemness and plasticity: new perspectives and therapeutic potential.
Roy S; Sunkara RR; Parmar MY; Shaikh S; Waghmare SK
Front Biosci (Landmark Ed); 2021 Jan; 26(2):238-265. PubMed ID: 33049669
[TBL] [Abstract][Full Text] [Related]
27. NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines.
Huergo-Zapico L; Parodi M; Cantoni C; Lavarello C; Fernández-Martínez JL; Petretto A; DeAndrés-Galiana EJ; Balsamo M; López-Soto A; Pietra G; Bugatti M; Munari E; Marconi M; Mingari MC; Vermi W; Moretta L; González S; Vitale M
Cancer Res; 2018 Jul; 78(14):3913-3925. PubMed ID: 29752261
[TBL] [Abstract][Full Text] [Related]
28. Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion.
Kurmyshkina O; Kovchur P; Schegoleva L; Volkova T
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899940
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic transition of tumor cells between epithelial- and mesenchymal-like state during adaptation to acidosis.
Zhang Y; Xu L; Wang P; Jian H; Shi X; Jia M; Mo L; Hu Z; Li H; Li J
Cell Cycle; 2019 Aug; 18(16):1938-1947. PubMed ID: 31234753
[TBL] [Abstract][Full Text] [Related]
30. Secreted molecules inducing epithelial-to-mesenchymal transition in cancer development.
Dalla Pozza E; Forciniti S; Palmieri M; Dando I
Semin Cell Dev Biol; 2018 Jun; 78():62-72. PubMed ID: 28673679
[TBL] [Abstract][Full Text] [Related]
31. Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.
BharathwajChetty B; Sajeev A; Vishwa R; Aswani BS; Alqahtani MS; Abbas M; Kunnumakkara AB
Cancer Metastasis Rev; 2024 Mar; 43(1):321-362. PubMed ID: 38517618
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancer.
Bedi U; Mishra VK; Wasilewski D; Scheel C; Johnsen SA
Oncotarget; 2014 Apr; 5(8):2016-29. PubMed ID: 24840099
[TBL] [Abstract][Full Text] [Related]
33. TGF-β, EMT, and resistance to anti-cancer treatment.
Wang X; Eichhorn PJA; Thiery JP
Semin Cancer Biol; 2023 Dec; 97():1-11. PubMed ID: 37944215
[TBL] [Abstract][Full Text] [Related]
34. Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma.
Fedele M; Cerchia L; Pegoraro S; Sgarra R; Manfioletti G
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167470
[TBL] [Abstract][Full Text] [Related]
35. Dynamic EMT: a multi-tool for tumor progression.
Brabletz S; Schuhwerk H; Brabletz T; Stemmler MP
EMBO J; 2021 Sep; 40(18):e108647. PubMed ID: 34459003
[TBL] [Abstract][Full Text] [Related]
36. Epithelial-Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics.
Chaves LP; Melo CM; Saggioro FP; Reis RBD; Squire JA
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946849
[TBL] [Abstract][Full Text] [Related]
37. Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer.
Esquer H; Zhou Q; Nemkov T; Abraham AD; Rinaldetti S; Chen YC; Zhang X; Orman MV; D'Alessandro A; Ferrer M; Messersmith WA; LaBarbera DV
Oncogene; 2021 Apr; 40(16):2884-2897. PubMed ID: 33742123
[TBL] [Abstract][Full Text] [Related]
38. Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis.
Dzobo K; Sinkala M
OMICS; 2021 May; 25(5):313-332. PubMed ID: 33961518
[TBL] [Abstract][Full Text] [Related]
39. Emerging roles of epithelial-mesenchymal plasticity in invasion-metastasis cascade and therapy resistance.
Garg M
Cancer Metastasis Rev; 2022 Mar; 41(1):131-145. PubMed ID: 34978017
[TBL] [Abstract][Full Text] [Related]
40. Tumor Plasticity and Resistance to Immunotherapy.
Horn LA; Fousek K; Palena C
Trends Cancer; 2020 May; 6(5):432-441. PubMed ID: 32348738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
